(NYSE:TMO) WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced the completion of its acquisition of the Purification & Filtration business of Solventum (NYSE: SOLV) for approximately $4.0 billion in cash. With the transaction complete, the business, which is now Thermo Fisher’s Filtration and Separation business, is part of the Life Sciences Solutions segment. The transaction includes Solventum’s Purificatio
Related Questions
What are the immediate effects of the $4 billion cash outlay on Thermo Fisher’s balance sheet and short‑term liquidity?
When will the acquisition start contributing to earnings per share and does it meet analyst expectations for accretion in FY2025‑26?
How might this deal reshape Thermo Fisher’s competitive position in the filtration and separation market and influence its valuation multiples relative to peers?